References
- Baumgartner, A. M., Jones, P. F., Baumgartner, W. A., & Black, C. T. (1979). Radioimmunoassay of hair for determining opiate-abuse histories. Journal of Nuclear Medicine, 20, 748–752.
- Baumgartner, W. A., Hill, V. A., & Blahd, W. H. (1898). Hair analysis for drugs of abuse. Journal of Forensic Sciences, 34, 1433–1453.
- Buoli, M., Caldiroli, A., & Serati, M. (2017). Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology, 13, 351–359. doi: 10.1080/17425255.2017.1281247.
- Eastwood, J. A., & Davison, E. (2016). Pregabalin concentrations in post-mortem blood-A two year study. Forensic Science International, 266, 197–201. doi: 10.1016/j.forsciint.2016.05.033.
- Elliott, S. P., Burke, T., & Smith, C. (2017). Determining the toxicological significance of pregabalin in fatalities. Forensic Science International, 62, 169–173.
- Evoy, K. E., Morrison, M. D., & Saklad, S. R. (2017). Abuse and misuse of pregabalin and gabapentin. Drugs, 77, 403–426. doi: 10.1007/s40265-017-0700-x.
- Freynhagen, R., Backonja, M., Schug, S., Lyndon, G., Parson, B., Watt, S., & Behar, R. (2016). Pregabalin for the treatment of drug and alcohol withdrawal symptoms: A comprehensive review. CNS Drugs, 30, 1191–1200. doi: 10.1007/s40263-016-0390-z.
- Halaby, A., Kassm, S. A., & Naja, W. J. (2015). Pregabalin dependence: A case report. Current Drug Safety, 10, 184–186. doi: 10.2174/1574886309666141022101956.
- Kelly, R. C., Mieczkowski, T., Sweeney, S. A., & Bourland, J. A. (2000). Hair analysis for drugs of abuse. Hair color and race differentials or systematic differences in drug preferences? Forensic Science International, 107, 63–86. doi: 10.1016/S0379-0738(99)00151-6.
- Kintz, P. (2012). Value of the concept of minimal detectable dosage in hair. Forensic Science International, 218, 28–30. doi: 10.1016/j.forsciint.2011.10.018.
- Madry, M. M., Kraemer, T., & Baumgartner, M. R. (2018). Systematic assessment of different solvents for the extraction of drugs of abuse and pharmaceuticals form from authentic hair pool. Forensic Science International, 282, 137–143. doi: 10.1016/j.forsciint.2017.11.027.
- Mutschler, J., Gastberger, S., Baumgartner, M. R., Grosshans, M., Seifritz, E., Quednow, B. B., & Herdener, M. (2016). Pregabalin use among opioid-addicted patients in Switzerland. Journal of Clinical Psychiatry, 77, 1202–1203. doi: 10.4088/JCP.15l10296.
- Pauly, C., Yegles, M., & Schneider, S. (2013). Pregabalin determination in hair by ultra-high-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 37, 676–679. doi: 10.1093/jat/bkt081.
- Pragst, F., & Balikova, M. A. (2006). State of the art in hair analysis for detection of drug and alcohol abuse. Clinica Chimica Acta, 370, 17–49. doi: 10.1016/j.cca.2006.02.019.
- Schjerning, O., Rosenzweig, M., Pottegard, A., Damkier, P., & Nielsen, J. (2016). Abuse potential of pregabalin: A systematic review. CNS Drugs, 30, 9–25. doi: 10.1007/s40263-015-0303-6.
- Shanthanna, H., Gilron, I., Rajarathinam, M., AlAmri, R., Kamath, S., Thabane, L., Dervereaux, P. J., & Bhandari, M. (2017). Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. PLOS Medicine, 14, e1002369. doi:10.1371/journal.pmed.1002369 doi: 10.1371/journal.pmed.1002369.
- Stramesi, C., Polla, M., Vignali, C., Zuccella, A., & Groppi, A. (2008). Segmental hair analysis in order to evaluate driving performance. Forensic Science International, 176, 34–37. doi: 10.1016/j.forsciint.2007.08.010.
- Zaccara, G., Giovannelli, F., Giorgi, F. S., Franco, V., Gasparini, S., & Benedetto, U. (2017). Tolerability of new antiepileptic drugs: A network meta-analysis. European Journal of Clinical Pharmacology, 73, 811–817. doi: 10.1007/s00228-017-2245-z.